Archive · 23 Jun 2025
Corona Remedies Appoints Four Independent Directors to Board
Corona Remedies, a company that makes medicines, has added four new people to its board of directors.
These new directors have different kinds of experience from other companies.
The company wants to get more expertise to help it make decisions.
The new board members include people who have worked in other companies and in different areas.
The company is focused on making medicines for women's health, diabetes, and other health problems.
The company is supported by an investment company.
Corona Remedies has appointed four new independent directors to its board.
The new directors include Ameetkumar Hiranyakumar Desai, Bhaskar Vemban Iyer, Shirish Gundopant Belapure, and Monica Hemal Kanuga.
The company aims to bring in diverse expertise and experience with these appointments.
Corona Remedies is a pharmaceutical company focused on women's healthcare, cardio-diabeto, and more.
The company is backed by Sepia Investments, an affiliate of ChrysCapital.
- Who
- Corona Remedies, Ameetkumar Hiranyakumar Desai, Bhaskar Vemban Iyer, Shirish Gundopant Belapure, and Monica Hemal Kanuga.
- What
- Corona Remedies appointed four new independent directors.
- When
- June 23, 2025 (publication date).
- Where
- The article does not specify a location.
- Why
- To bring in diverse expertise and experience.
- Company
- Corona Remedies
- New Directors
- Ameetkumar Hiranyakumar Desai, Bhaskar Vemban Iyer, Shirish Gundopant Belapure, Monica Hemal Kanuga
- Focus
- Women’s healthcare, cardio-diabeto, pain management, urology
- Backed by
- Sepia Investments (ChrysCapital)